NCT07653269 Predicting Risk of Progression of Early to Late AMD in the Aging Eye Through Imaging and Multimodal Evaluation
| NCT ID | NCT07653269 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Singapore National Eye Centre |
| Condition | Age Related Macular Degeneration |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,500 participants |
| Start Date | 2025-10-18 |
| Primary Completion | 2029-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,500 participants in total. It began in 2025-10-18 with a primary completion date of 2029-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this research study is to evaluate a new screening procedure for the early detection and monitoring of Age-related Macular Degeneration (AMD) in community settings and community hospital settings, to identify associated risk factors, and develop personalized monitoring strategies for at-risk individuals throughout the 5 years follow up period, which will allow us to establish prevalence, natural history of progression of early AMD in the community.
Eligibility Criteria
Inclusion Criteria: * Adults aged 55 years or older * No severe systemic illnesses that prevent study participation * Willing and able to undergo protocol-required procedures for both eyes * Willing and able to provide written informed consent Exclusion Criteria: * Systemic disorders that preclude reliable clinical examination or multimodal imaging * Poor compliance or severe mental illness that hinders participation * Persons who are unable to give informed consent
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07653269 clinical trial?
This trial is open to participants of all sexes, aged 55 Years or older, studying Age Related Macular Degeneration. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07653269 currently recruiting?
Yes, NCT07653269 is actively recruiting participants. Contact the research team at gemmy.cheung.c.m@singhealth.com.sg for enrollment information.
Where is the NCT07653269 trial being conducted?
This trial is being conducted at Singapore, Singapore, Singapore, Singapore.
Who is sponsoring the NCT07653269 clinical trial?
NCT07653269 is sponsored by Singapore National Eye Centre. The trial plans to enroll 1,500 participants.